New Research Finds Phase 3 is the Most Popular Stage for Medical Affairs Teams to Begin Thought Leader Development Activities
08 mai 2017 19h30 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - May 08, 2017) - Between both Phase 3a and 3b, 50% of surveyed teams begin their thought leader development activities, with the next most popular stage to...
FMV Budget is a Top Criterion Among Surveyed Companies When Evaluating IIT Proposals
21 févr. 2017 08h36 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - February 21, 2017) - Nearly one-third of surveyed pharmaceutical companies look to fair-market value (FMV) budget as one their most important criteria for...
Medical Affairs Teams Undertake Launch Planning Activities as Early as Three Years Ahead of Product Launch, Says New Research
26 janv. 2017 07h39 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - January 26, 2017) - Launch planning is an essential component of life science teams' ongoing activities. As new life science products approach the launch...
Pharma to Clinical Investigators: Reach Target Patient Enrollment or You Don't Get Paid
11 oct. 2016 09h08 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - October 11, 2016) - A study published by Cutting Edge Information found that 87% of surveyed pharmaceutical companies would not submit next-level clinical...
77% of Investigator-Initiated Trial Committees With Complete Voting Privileges Let High-Level Executives Make Final Decisions
28 juin 2016 08h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 28, 2016) - Investigator-initiated trial (IIT) review committees are often small and contain individuals from a variety of backgrounds. Most...
75 Percent of Drug Companies Formally Manage Investigator-Initiated Trials
03 mars 2010 09h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - March 3, 2010) - Investigator-initiated trials (IITs) provide companies with clinical data to expand scientific understanding of their drugs and reap a...